General Anesthesia

• FDA approval · 2025-10-16
  FDA Approved: SEVOFLURANE — Supplemental Application (Piramal Critical Care Inc)

  The FDA approved a supplemental application for Sevoflurane from Piramal Critical Care Inc.

• FDA approval · 2024-10-03
  FDA Approved: METHOHEXITAL SODIUM — Original Application (ONESOURCE SPECIALTY PHARMA LIMITED)

  FDA approved a generic methohexital sodium product for anesthesia induction under ANDA215488 by Onesource Specialty Pharma Limited.

• FDA approval · 2022-11-01
  FDA Approved: ULTANE — Supplemental Application (AbbVie Inc.)

  The FDA approved a supplemental application for ULTANE (sevoflurane) submitted by AbbVie.

• FDA approval · 2020-11-03
  FDA Approved: BREVITAL SODIUM — Supplemental Application (Par Health USA, LLC)

  FDA approved a supplemental application for Brevital Sodium (methohexital sodium) from Par Health USA, LLC.

• FDA approval · 2020-10-13
  FDA Approved: REMIFENTANIL HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved Hikma's original-application ANDA for remifentanil hydrochloride, a generic opioid analgesic used to provide anesthesia during …

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2018-03-07
  FDA Approved: ETOMIDATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  The FDA approved a supplemental application for Etomidate from Hikma Pharmaceuticals USA Inc. under ANDA 202354.

• FDA approval · 2017-12-22
  FDA Approved: PROPOFOL — Supplemental Application (Sagent Pharmaceuticals)

  FDA approved a supplemental application for propofol from Sagent Pharmaceuticals, indicating an expanded or updated regulatory approval for …

• FDA approval · 2017-04-27
  FDA Approved: FORANE — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved a supplemental application for FORANE (isoflurane) submitted by Baxter Healthcare Corporation.

• FDA approval · 2017-04-27
  FDA Approved: SUPRANE — Supplemental Application (Baxter Healthcare Corporation)

  The FDA approved a supplemental application for SUPRANE (desflurane) by Baxter Healthcare Corporation.

• FDA approval · 2016-07-05
  FDA Approved: PROPOFOL — Supplemental Application (Sagent Pharmaceuticals)

  FDA approved a supplemental application for Propofol filed by Sagent Pharmaceuticals (ANDA075102).

• FDA approval · 2016-02-25
  FDA Approved: ETOMIDATE — Original Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved the original application for etomidate from Hikma Pharmaceuticals USA Inc., making a generic etomidate available for induction …

• FDA approval · 2013-09-27
  FDA Approved: SUPRANE — Supplemental Application (Baxter Healthcare Corporation)

  FDA approved a supplemental application for SUPRANE (desflurane) by Baxter Healthcare Corporation, updating labeling details for the anesthe…

• FDA approval · 2013-06-16
  FDA Approved: NITROUS OXIDE — Original Application (United States Welding, Inc.)

  FDA approves the original application for Nitrous Oxide from United States Welding, Inc., confirming its use as an inhaled anesthetic.

• FDA approval · 2010-11-22
  FDA Approved: QUELICIN — Supplemental Application (Hospira, Inc.)

  The FDA approved a supplemental application for Quelicin (succinylcholine chloride) submitted by Hospira, Inc., updating the existing produc…

• FDA approval · 2009-08-10
  FDA Approved: TERRELL — Supplemental Application (Piramal Critical Care Inc)

  FDA approved a supplemental application for TERRELL (isoflurane) from Piramal Critical Care Inc, updating the product's approval for use as …

• FDA approval · 2008-11-26
  FDA Approved: ROCURONIUM BROMIDE — Original Application (Mylan Institutional LLC)

  FDA approves Rocuronium bromide under an Original Application (ANDA) for generic use as a neuromuscular blocker to facilitate tracheal intub…

• FDA approval · 2008-08-12
  FDA Approved: PROPOFOL — Supplemental Application (Hospira, Inc.)

  FDA approved Hospira's supplemental application for Propofol for use as an anesthetic/sedative agent.

• FDA approval · 2008-01-02
  FDA Approved: PROPOFOL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

  FDA approved a supplemental application for Propofol submitted by Hikma Pharmaceuticals USA Inc., authorizing the marketing of a generic pro…